Literature DB >> 21192659

A practical use of ligand efficiency indices out of the fragment-based approach: ligand efficiency-guided lead identification of soluble epoxide hydrolase inhibitors.

Daisuke Tanaka1, Yusuke Tsuda, Takaaki Shiyama, Tamiki Nishimura, Naoki Chiyo, Yukio Tominaga, Nobuyuki Sawada, Tsutomu Mimoto, Naoto Kusunose.   

Abstract

Ligand efficiency is frequently used to evaluate fragment compounds in fragment-based drug discovery. We applied ligand efficiency indices in a conventional virtual screening-initiated lead generation study of soluble epoxide hydrolase inhibitors. From a considerable number of screening hits, we carefully selected a compound exhibiting relatively weak inhibitory activity but high ligand efficiency. This ligand efficiency-guided selection could reveal compounds possessing preferable lead-like characteristics in terms of molecular size and lipophilicity. The following hit-to-lead medicinal chemistry campaign successfully led to a more potent, ADMET-clean, lead-like compound preserving high ligand efficiency. Retrospective analyses, including consideration of the more recently proposed indices of ligand efficiency, shed light on the validity of our hit triage and hit-to-lead studies. The present work proposes a practical methodology for lead generation using the concept of ligand efficiency.

Mesh:

Substances:

Year:  2010        PMID: 21192659     DOI: 10.1021/jm101273e

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  20 in total

Review 1.  Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications.

Authors:  Hong C Shen; Bruce D Hammock
Journal:  J Med Chem       Date:  2012-01-17       Impact factor: 7.446

2.  Fragment-based drug discovery using a multidomain, parallel MD-MM/PBSA screening protocol.

Authors:  Tian Zhu; Hyun Lee; Hao Lei; Christopher Jones; Kavankumar Patel; Michael E Johnson; Kirk E Hevener
Journal:  J Chem Inf Model       Date:  2013-03-14       Impact factor: 4.956

3.  Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA.

Authors:  Leila Karami; Ali Akbar Saboury; Elham Rezaee; Sayyed Abbas Tabatabai
Journal:  Eur Biophys J       Date:  2016-12-07       Impact factor: 1.733

4.  Formation of activity cliffs is accompanied by systematic increases in ligand efficiency from lowly to highly potent compounds.

Authors:  Antonio de la Vega de León; Jürgen Bajorath
Journal:  AAPS J       Date:  2014-01-30       Impact factor: 4.009

5.  Protein-observed (19)F-NMR for fragment screening, affinity quantification and druggability assessment.

Authors:  Clifford T Gee; Keith E Arntson; Andrew K Urick; Neeraj K Mishra; Laura M L Hawk; Andrea J Wisniewski; William C K Pomerantz
Journal:  Nat Protoc       Date:  2016-07-14       Impact factor: 13.491

Review 6.  Replacing sulfa drugs with novel DHPS inhibitors.

Authors:  Dalia I Hammoudeh; Ying Zhao; Stephen W White; Richard E Lee
Journal:  Future Med Chem       Date:  2013-07       Impact factor: 3.808

7.  Repositioning of Quinazolinedione-Based Compounds on Soluble Epoxide Hydrolase (sEH) through 3D Structure-Based Pharmacophore Model-Driven Investigation.

Authors:  Erica Gazzillo; Stefania Terracciano; Dafne Ruggiero; Marianna Potenza; Maria Giovanna Chini; Gianluigi Lauro; Katrin Fischer; Robert Klaus Hofstetter; Assunta Giordano; Oliver Werz; Ines Bruno; Giuseppe Bifulco
Journal:  Molecules       Date:  2022-06-16       Impact factor: 4.927

8.  Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain.

Authors:  Kin Sing Stephen Lee; Jen C Ng; Jun Yang; Sung-Hee Hwang; Christophe Morisseau; Karen Wagner; Bruce D Hammock
Journal:  Bioorg Med Chem       Date:  2020-08-31       Impact factor: 3.641

Review 9.  Back to the future: lessons learned in modern target-based and whole-cell lead optimization of antimalarials.

Authors:  Arnab K Chatterjee; Bryan K S Yeung
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

10.  Novel 9-(alkylthio)-Acenaphtho[1,2-e]-1,2,4-triazine derivatives: synthesis, cytotoxic activity and molecular docking studies on B-cell lymphoma 2 (Bcl-2).

Authors:  Mohammad K Mohammadi; Omidreza Firuzi; Mehdi Khoshneviszadeh; Nima Razzaghi-Asl; Saghi Sepehri; Ramin Miri
Journal:  Daru       Date:  2014-01-06       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.